HOUSTON, Aug. 23, 2019 /PRNewswire/ -- Phyllis Okereke, MD, FAARFM with Shioma Anti-Aging is implementing a non-invasive and drug-free solution for Erectile Dysfunction (ED). This cutting-edge procedure boasts a 75% success rate amongst patients. The treatment is called

ODESSA, Texas, Aug. 23, 2019 /PRNewswire/ -- Charles Lively MD is implementing a non-invasive and drug-free solution for Erectile Dysfunction (ED). This cutting-edge procedure boasts a 75% success rate amongst patients. The treatment is called

PAYSON, Utah, Aug. 23, 2019 /PRNewswire/ -- Jennifer Trinidad, with Body Renaissance is implementing a non-invasive and drug-free solution for Erectile Dysfunction (ED). This cutting-edge procedure boasts a 75% success rate amongst patients. The treatment is called

BLOOMINGTON, Ind., Aug. 23, 2019 /PRNewswire/ -- Philip C. Brittain, DO with Vibrant Life is implementing a non-invasive and drug-free solution for Erectile Dysfunction (ED). This cutting-edge procedure boasts a 75% success rate amongst patients. The treatment is called

SHANGHAI, Aug. 23, 2019 /PRNewswire/ -- The world largest online healthcare platform, Ping An Good Doctor (01833.HK), has seen its share price rise sharply recently, closing at HK $48.35 on 23 August, up 6.73%. The company's share price has soared by 48.7% since they announced the 1H2019 earning results on 6&nb

DALLAS, Aug. 23, 2019 /PRNewswire/ -- Parks Associates will examine the market for IoT health solutions and current trends in the connected health market during "

BOCA RATON, Fla., Aug. 23, 2019 /PRNewswire/ -- IM HealthScience® (IMH), innovators of medical foods and dietary supplements, today announced that a high-quality, nationwide survey, conducted among a representative and projectable sample of U.S. gastroenterologists, revealed Fiber Choice® as the #1-recommended chewable fiber brand.

BOCA RATON, Fla., Aug. 23, 2019 /PRNewswire/ -- IM HealthScience®, innovators of medical foods and dietary supplements, today announced that a high-quality, nationwide survey, conducted among a representative and projectable sample of U.S. gastroenterologists, revealed FDgard® as the #1-recommended product for Functional Dyspepsi

REDWOOD CITY, Calif., Aug. 23, 2019 /PRNewswire/ -- Nevro Corp. (NYSE: NVRO), a global medical device company that is providing innovative, evidence-based solutions for the treatment of chronic pain, today announced the Company will be participating in the Morgan Stanley 17th Annual Healthcare Conference in New York City

BOSTON, Aug. 23, 2019 /PRNewswire/ -- HotSpot Therapeutics, Inc, a biotechnology company pioneering the discovery of nature's regulatory sites to advance allosteric drug discovery, today announced the acquisition of Macroceutics, Inc., a provider of DNA-encoded library (DEL) screening technologies. The outgrowth of a strategic collaboration, the acquisition will enhance